Your browser doesn't support javascript.
loading
The operational impact of deploying SARS-CoV-2 vaccines in countries of the WHO African Region.
Ortiz, Justin R; Robertson, Joanie; Hsu, Jui-Shan; Yu, Stephen L; Driscoll, Amanda J; Williams, Sarah R; Chen, Wilbur H; Fitzpatrick, Meagan C; Sow, Samba; Biellik, Robin J; Okwo-Bele, Jean-Marie; Neuzil, Kathleen M.
Afiliação
  • Ortiz JR; Center for Vaccine Development and Global Health, 685 W. Baltimore St., University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Robertson J; PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA.
  • Hsu JS; PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA.
  • Yu SL; Center for Vaccine Development and Global Health, 685 W. Baltimore St., University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Driscoll AJ; Center for Vaccine Development and Global Health, 685 W. Baltimore St., University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Williams SR; Division of Pulmonary and Critical Care Medicine, 110 S. Paca St, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Chen WH; Center for Vaccine Development and Global Health, 685 W. Baltimore St., University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Fitzpatrick MC; Center for Vaccine Development and Global Health, 685 W. Baltimore St., University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Sow S; Centre pour le Développement des Vaccins, Ministère de la Santé, BP251Bamako, Mali.
  • Biellik RJ; Independent Consultant, Tranchepied 10, 1278 La Rippe, Switzerland.
  • Okwo-Bele JM; Independent Consultant, Chemin de la Poste 6, 1295 Founex, Switzerland.
  • Neuzil KM; Center for Vaccine Development and Global Health, 685 W. Baltimore St., University of Maryland School of Medicine, Baltimore, Maryland, USA.
medRxiv ; 2020 Nov 01.
Article em En | MEDLINE | ID: mdl-32817984